From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancer
Factors | Hazard ratio | 95% CI | p value |
---|---|---|---|
New lesions at second chemotherapy | 1.02 | 0.54–1.93 | 0.95 |
ER (+) | 0.28 | 0.16–0.48 | < 0.01 |
Targeted therapy alone | 0.27 | 0.12–0.62 | < 0.01 |
Eribulin administration | 0.49 | 0.24–0.99 | < 0.05 |
Visceral metastasis at first recurrence | 1.10 | 0.70–1.73 | 0.68 |